Rock Springs Capital Management as of June 30, 2023
Portfolio Holdings for Rock Springs Capital Management
Rock Springs Capital Management holds 123 positions in its portfolio as reported in the June 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Humana (HUM) | 5.0 | $210M | 470k | 447.13 | |
Immunocore Hldgs Ads (IMCR) | 4.3 | $182M | 3.0M | 59.96 | |
Insulet Corporation (PODD) | 3.8 | $161M | 559k | 288.34 | |
Agilon Health (AGL) | 3.4 | $144M | 8.3M | 17.34 | |
Blueprint Medicines (BPMC) | 3.3 | $138M | 2.2M | 63.20 | |
Argenx Se Sponsored Adr (ARGX) | 3.2 | $136M | 350k | 389.73 | |
Penumbra (PEN) | 3.0 | $126M | 366k | 344.06 | |
Neurocrine Biosciences (NBIX) | 2.9 | $121M | 1.3M | 94.30 | |
Evolent Health Cl A (EVH) | 2.7 | $115M | 3.8M | 30.30 | |
UnitedHealth (UNH) | 2.6 | $111M | 230k | 480.64 | |
Karuna Therapeutics Ord | 2.5 | $107M | 494k | 216.85 | |
Intuitive Surgical Com New (ISRG) | 2.4 | $102M | 299k | 341.94 | |
IDEXX Laboratories (IDXX) | 2.3 | $98M | 195k | 502.23 | |
EXACT Sciences Corporation (EXAS) | 2.1 | $89M | 944k | 93.90 | |
Cerevel Therapeutics Hldng I (CERE) | 1.9 | $80M | 2.5M | 31.79 | |
West Pharmaceutical Services (WST) | 1.8 | $77M | 202k | 382.47 | |
Seagen | 1.8 | $77M | 400k | 192.46 | |
Align Technology (ALGN) | 1.8 | $77M | 217k | 353.64 | |
Agios Pharmaceuticals (AGIO) | 1.8 | $76M | 2.7M | 28.32 | |
Akero Therapeutics (AKRO) | 1.7 | $72M | 1.6M | 46.69 | |
Acadia Healthcare (ACHC) | 1.7 | $72M | 908k | 79.64 | |
Alnylam Pharmaceuticals (ALNY) | 1.6 | $66M | 345k | 189.94 | |
Ultragenyx Pharmaceutical (RARE) | 1.5 | $64M | 1.4M | 46.13 | |
Dex (DXCM) | 1.5 | $63M | 491k | 128.51 | |
Edwards Lifesciences (EW) | 1.4 | $61M | 646k | 94.33 | |
Abcam Ads | 1.4 | $59M | 2.4M | 24.47 | |
Prothena Corp SHS (PRTA) | 1.2 | $51M | 754k | 68.28 | |
Horizon Therapeutics Pub L SHS | 1.2 | $51M | 495k | 102.85 | |
Sarepta Therapeutics (SRPT) | 1.2 | $49M | 425k | 114.52 | |
Mirum Pharmaceuticals (MIRM) | 1.1 | $47M | 1.8M | 25.87 | |
Madrigal Pharmaceuticals (MDGL) | 1.1 | $46M | 199k | 231.00 | |
Xenon Pharmaceuticals (XENE) | 1.1 | $45M | 1.2M | 38.50 | |
Freshpet (FRPT) | 1.0 | $44M | 663k | 65.81 | |
Pacira Pharmaceuticals (PCRX) | 1.0 | $42M | 1.0M | 40.07 | |
Aclaris Therapeutics (ACRS) | 1.0 | $41M | 4.0M | 10.37 | |
Mirati Therapeutics | 1.0 | $41M | 1.1M | 36.13 | |
Phreesia (PHR) | 1.0 | $41M | 1.3M | 31.01 | |
Accolade (ACCD) | 0.9 | $38M | 2.8M | 13.47 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.9 | $38M | 426k | 89.25 | |
Kymera Therapeutics (KYMR) | 0.8 | $34M | 1.5M | 22.99 | |
Zai Lab Adr (ZLAB) | 0.8 | $34M | 1.2M | 27.73 | |
Amylyx Pharmaceuticals (AMLX) | 0.8 | $33M | 1.5M | 21.57 | |
Shockwave Med | 0.8 | $33M | 115k | 285.41 | |
Irhythm Technologies (IRTC) | 0.8 | $32M | 310k | 104.32 | |
Legend Biotech Corp Sponsored Ads (LEGN) | 0.8 | $32M | 458k | 69.03 | |
Olink Hldg Ab Sponsored Ads (OLK) | 0.7 | $31M | 1.7M | 18.75 | |
Nevro (NVRO) | 0.7 | $31M | 1.2M | 25.42 | |
Immatics SHS (IMTX) | 0.7 | $29M | 2.5M | 11.54 | |
CONMED Corporation (CNMD) | 0.7 | $28M | 205k | 135.89 | |
Select Sector Spdr Tr Sbi Healthcare (XLV) | 0.6 | $27M | 200k | 132.73 | |
Lifestance Health Group (LFST) | 0.6 | $27M | 2.9M | 9.13 | |
Rhythm Pharmaceuticals (RYTM) | 0.6 | $26M | 1.6M | 16.49 | |
Travere Therapeutics (TVTX) | 0.6 | $24M | 1.5M | 15.36 | |
Dynavax Technologies Corp Com New (DVAX) | 0.6 | $23M | 1.8M | 12.92 | |
BioMarin Pharmaceutical (BMRN) | 0.5 | $23M | 265k | 86.68 | |
Brooks Automation (AZTA) | 0.5 | $22M | 470k | 46.68 | |
Mineralys Therapeutics (MLYS) | 0.5 | $20M | 1.2M | 17.05 | |
Inozyme Pharma (INZY) | 0.5 | $19M | 3.4M | 5.57 | |
Revolution Medicines (RVMD) | 0.4 | $19M | 703k | 26.75 | |
Biomea Fusion (BMEA) | 0.4 | $18M | 837k | 21.95 | |
BioCryst Pharmaceuticals (BCRX) | 0.4 | $18M | 2.5M | 7.04 | |
Compass Therapeutics (CMPX) | 0.4 | $18M | 5.5M | 3.18 | |
Disc Medicine (IRON) | 0.4 | $16M | 364k | 44.40 | |
Warby Parker Cl A Com (WRBY) | 0.4 | $16M | 1.3M | 11.69 | |
Chinook Therapeutics | 0.4 | $15M | 396k | 38.42 | |
Cytokinetics Com New (CYTK) | 0.3 | $15M | 448k | 32.62 | |
Boston Scientific Corporation (BSX) | 0.3 | $15M | 268k | 54.09 | |
Celldex Therapeutics Com New (CLDX) | 0.3 | $14M | 422k | 33.93 | |
Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.3 | $14M | 650k | 21.49 | |
Amicus Therapeutics (FOLD) | 0.3 | $13M | 1.1M | 12.56 | |
Merus N V (MRUS) | 0.3 | $13M | 479k | 26.33 | |
Aura Biosciences (AURA) | 0.3 | $13M | 1.0M | 12.35 | |
Health Catalyst (HCAT) | 0.3 | $12M | 930k | 12.50 | |
Mersana Therapeutics (MRSN) | 0.3 | $11M | 3.4M | 3.29 | |
Edap Tms S A Sponsored Adr (EDAP) | 0.3 | $11M | 1.2M | 9.22 | |
Biohaven (BHVN) | 0.2 | $9.6M | 402k | 23.92 | |
Mereo Biopharma Group Spon Ads (MREO) | 0.2 | $9.3M | 7.0M | 1.32 | |
Pliant Therapeutics (PLRX) | 0.2 | $8.9M | 491k | 18.12 | |
Icosavax | 0.2 | $8.6M | 868k | 9.93 | |
Pulmonx Corp (LUNG) | 0.2 | $8.6M | 652k | 13.11 | |
Relay Therapeutics (RLAY) | 0.2 | $8.5M | 674k | 12.56 | |
Reneo Pharmaceuticals (RPHM) | 0.2 | $7.5M | 1.1M | 6.56 | |
Guardant Health (GH) | 0.2 | $7.2M | 200k | 35.80 | |
Anaptysbio Inc Common (ANAB) | 0.2 | $6.9M | 342k | 20.34 | |
Macrogenics (MGNX) | 0.1 | $6.0M | 1.1M | 5.35 | |
Spruce Biosciences (SPRB) | 0.1 | $5.9M | 2.7M | 2.15 | |
Novocure Ord Shs (NVCR) | 0.1 | $5.2M | 125k | 41.50 | |
Aurinia Pharmaceuticals (AUPH) | 0.1 | $4.6M | 480k | 9.68 | |
Vigil Neuroscience (VIGL) | 0.1 | $4.4M | 472k | 9.40 | |
Krystal Biotech (KRYS) | 0.1 | $4.1M | 35k | 117.40 | |
Theseus Pharmaceuticals | 0.1 | $4.1M | 437k | 9.33 | |
Novavax Com New (NVAX) | 0.1 | $4.0M | 537k | 7.43 | |
Paratek Pharmaceuticals | 0.1 | $3.8M | 1.7M | 2.21 | |
Xilio Therapeutics (XLO) | 0.1 | $3.8M | 1.4M | 2.62 | |
Beam Therapeutics (BEAM) | 0.1 | $3.6M | 111k | 31.93 | |
Leap Therapeutics Com New (LPTX) | 0.1 | $3.4M | 1.1M | 3.13 | |
Acelyrin (SLRN) | 0.1 | $3.0M | 142k | 20.90 | |
Fate Therapeutics (FATE) | 0.1 | $2.9M | 612k | 4.76 | |
Design Therapeutics (DSGN) | 0.1 | $2.9M | 460k | 6.30 | |
Gossamer Bio Note 5.000% 6/0 (Principal) | 0.1 | $2.9M | 9.6M | 0.30 | |
Travere Therapeutics Note 2.500% 9/1 (Principal) | 0.1 | $2.9M | 3.3M | 0.88 | |
Black Diamond Therapeutics (BDTX) | 0.1 | $2.8M | 563k | 5.05 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $2.6M | 2.8M | 0.93 | |
Fulcrum Therapeutics (FULC) | 0.1 | $2.4M | 728k | 3.30 | |
Kinnate Biopharma | 0.1 | $2.3M | 747k | 3.03 | |
ImmunoGen | 0.1 | $2.1M | 113k | 18.87 | |
Invitae (NVTAQ) | 0.0 | $1.9M | 1.7M | 1.13 | |
Essa Pharma Com New (EPIX) | 0.0 | $1.8M | 663k | 2.70 | |
Aeglea Biotherapeutics | 0.0 | $1.5M | 3.4M | 0.45 | |
Compugen Ord (CGEN) | 0.0 | $1.5M | 1.3M | 1.14 | |
Gamida Cell SHS | 0.0 | $1.4M | 715k | 1.93 | |
Gossamer Bio (GOSS) | 0.0 | $1.3M | 1.1M | 1.20 | |
Neurocrine Biosciences Note 2.250% 5/1 (Principal) | 0.0 | $1.3M | 1.0M | 1.28 | |
Vincerx Pharma Com New (VINC) | 0.0 | $1.2M | 892k | 1.30 | |
Applied Therapeutics (APLT) | 0.0 | $999k | 781k | 1.28 | |
Spero Therapeutics (SPRO) | 0.0 | $971k | 670k | 1.45 | |
Altimmune Com New (ALT) | 0.0 | $788k | 223k | 3.53 | |
Nkarta (NKTX) | 0.0 | $726k | 332k | 2.19 | |
Tempest Therapeutics (TPST) | 0.0 | $681k | 536k | 1.27 | |
Nevro Corp Note 2.750% 4/0 (Principal) | 0.0 | $463k | 500k | 0.92 | |
Atreca Cl A Com (BCEL) | 0.0 | $355k | 363k | 0.98 | |
Acelrx Pharmaceuticals Com New (TLPH) | 0.0 | $351k | 317k | 1.11 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $22k | 134k | 0.17 |